The Quattro valve in rheumatic mitral valve disease: Four-year follow up

Journal of Heart Valve Disease

Volumn 12, Issue 6, 2003, Pages 758-763

  Middlemost, Shirley J ^a,b   Manga, Pravin ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b NONE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ADULT; ARTICLE; CATTLE; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DETERIORATION; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ENDOCARDITIS; EXPLANT; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FUNCTION; HEART VALVE PROSTHESIS; HEART VENTRICLE HYPERTROPHY; HEMATEMESIS; HEMOLYSIS; HUMAN; ISOLATED HEART; LONG TERM CARE; MALE; MITRAL VALVE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; MITRAL VALVE STENOSIS; MORTALITY; PERICARDIUM; PEROPERATIVE ECHOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE; SATISFACTION; SYMPTOMATOLOGY; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

ADULT; BIOPROSTHESIS; COHORT STUDIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; POSTOPERATIVE COMPLICATIONS; PROBABILITY; PROSTHESIS DESIGN; PROSTHESIS FAILURE; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; RHEUMATIC HEART DISEASE; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 0345134194     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Middlemost SJ, Sussman M, Patel A, Manga P. The stentless bovine pericardial valve: Early clinical results. J Heart Valve Dis 1999;8:174-179
2. Walther T, Walther C, Flak V, et al. Early clinical results after stentless mitral valve implantation and comparison with conventional valve repair or replacement. Circulation 1999;100(suppl.II);II-78-II-83
3. Thomas JD, Weyman AE. Doppler mitral pressure half-time: A clinical tool in search of theoretical justification. J Am Coll Cardiol 1987;10:923-929
4. Nakatani S, Massuyama T, Kodama K, et al. Value and limitations of Doppler echocardiography in the quantification of stenotic mitral valve area: Comparison of the pressure half-time and continuity equation methods. Circulation 1988;77:78-85
5. Helmcke F, Nanda NC, Hsiung MC, et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 1987;75:175-183
6. Vranderic M, Gontijo B, Fantini FA, et al. Porcine mitral stentless valve mid-term clinical results. Eur J Cardiothorac Surg 1997;12:56-62
7. McClung JA, Stein JH, Ambrose JA, Herman MV, Reed GE. Prosthetic heart valve: A review. Prog Cardiovasc Dis 1983;26:237-271
8. Perier P, Deloche A, Chauvaud S, et al. A 10-year comparison of mitral valve replacement with Carpentier-Edwards and Hancock porcine bioprostheses. Ann Thorac Surg 1989;48:54-59
9. Oyer PE, Stinson EB, Reitz BA, Craig-Miller D, Rossiter SD, Shumway NE. Long-term evaluation of the porcine xenograft bioprosthesis. J Thorac Cardiovasc Surg 1979;78:343-350
10. Perier P, Deloche A, Chauvaud S, et al. Comparative evaluation of mitral valve repair and replacement using the Starr, Björk and porcine valve prostheses. Circulation 1984;70(suppl.I):187-192
11. Heras M, Chesebro JH, Fuster V, et al. High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol 1995;25:1111-1119
12. Stein B, Fuster V, Halperin JL, Chesebro JH. Antithrombotic therapy in cardiac disease: An emerging approach based on pathogenesis and risk. Circulation 1989;80:1501-1513
13. Chesebro JH, Adams PC, Fuster V. Antithrombotic therapy in patients with valvular heart disease and prosthetic heart valves. J Am Coll Cardiol 1986;8(suppl.B):41B-56B
14. Cohn LH, Allred EN, Cohn LA, et al. Early and late risk of mitral valve replacement. A 12-year concomitant comparison of the porcine bioprosthetic and prosthetic disc mitral valves. J Thorac Cardiovasc Surg 1985;90:872-881
15. Louagie YA, Jamart J, Eucher P, et al. Mitral valve Carpentier-Edwards bioprosthetic replacement, thromboembolism, and anticoagulants. Ann Thorac Surg 1993;56:931-937
16. Pelletier LC, Carrier M, Leclerc Y, Dyrda I. The Carpentier-Edwards pericardial bioprosthesis: Clinical experience with 600 patients. Ann Thorac Surg 1995;60:S297-S302
17. Wheatley DJ, Tolland MM, Pathi V, et al. Randomized, prospective evaluation of a new pericardial heart valve: Outcome after seven years. Eur J Cardiothorac Surg 1995;9:259-268
18. Rao V, Tong C, Ivanov J, Sever J, Goldman BS. Mitral valve replacement: mechanical versus bioprosthetic valves: A clinical review. Can J Cardiol 1991;7:259-264
19. Hoffman D, Gong G, Liao K, Macaluso F, Nikolic SD, Frater RWM. Spontaneous host endothelial growth on bioprosthesis. Influence of fixation. Circulation 1992;86(5Suppl.):75-79
20. Antunes MJ, Santos LP. Performance of glutaraldehyde-preserved porcine bioprosthesis as a mitral valve substitute in a young population group. Ann Thorac Surg 1984;37:387-392
21. Khan S, Mitchell S, Derby G, Oyer PE, Miller C. Hemodynamic comparison of Hancock and Carpentier-Edwards mitral bioprosthetic valves. Circulation 1990;82(suppl.IV):IV-78-IV-81
22. Rasmussen K, Vesterlund T, Vejlsted H. A hemodynamic study of the Carpentier-Edwards and Hancock porcine xenografts in the mitral position. Scand J Thorac Cardiovasc Surg 1984;18:37-40